Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:53:07.154Z.
Calculation as of: 2026-10-06T18:53:07.154Z.
Quote observation: 2026-10-06T18:50:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 69957a8c264286ff6eaa706b48c8270e863bf40c8b9bfd4321b5f2d082882a11
EARNINGS YIELD
N/A
Market Cap
$205.23M
Earnings Yield
N/A
TTM Avg
0.25%
3Y Avg
0.25%
5Y Avg
0.25%
Market Cap
$204.79M
Earnings Yield
N/A
TTM Avg
19.04%
3Y Avg
19.04%
5Y Avg
19.04%
Market Cap
$210.79M
Earnings Yield
N/A
TTM Avg
14.25%
3Y Avg
12.26%
5Y Avg
12.26%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | $206.15M | N/A | N/A | N/A | N/A |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.23M | N/A | 0.25% | 0.25% | 0.25% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.98M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $204.79M | N/A | 19.04% | 19.04% | 19.04% |
| Pro-Dex, Inc. (PDEX)vs › | $208.20M | 6.32% | 7.28% | 6.45% | 6.38% |
| Exagen Inc. (XGN)vs › | $201.86M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $201.70M | N/A | 3.98% | 3.98% | 3.98% |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.79M | N/A | 14.25% | 12.26% | 12.26% |
| Surrozen, Inc. (SRZN)vs › | $199.57M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $211.80M | 16.76% | 15.50% | 9.57% | 9.57% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
